UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy

Annals of oncology, 2018-04, Vol.29 (4), p.945-952

2018

Volltextzugriff (PDF)

Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial

Annals of oncology, 2021-04, Vol.32 (4), p.512-521

2021

Volltextzugriff (PDF)

Prognostic value of Ki-67 in patients with triple-negative breast cancer receiving neo-adjuvant or adjuvant chemotherapy: A systematic review and meta-analysis

Annals of oncology, 2019-05, Vol.30, p.iii15-iii15

2019

Volltextzugriff (PDF)

Controlling nutritional status (CONUT) score is a prognostic factor in patients with resected breast cancer

Annals of oncology, 2019-05, Vol.30, p.iii20-iii20

2019

Volltextzugriff (PDF)

Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial

Annals of oncology, 2014-12, Vol.25 (12), p.2385-2391

2014

Volltextzugriff (PDF)

Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild type advanced NSCLC

Annals of oncology, 2018-11, Vol.29, p.ix165-ix165

2018

Volltextzugriff (PDF)

Pilot study of anxiety, depression, and quality of life in patients with the diagnosis of metastatic uveal melanoma

Annals of oncology, 2018-10, Vol.29, p.viii560-viii560

2018

Volltextzugriff (PDF)

Osimertinib in advanced or metastatic non-small cell lung cancer patients with EGFR T790M mutation after treatment with EGFR-TKI: Interim analysis of China cohort from the single-arm, open-label, international, multi-center real-world ASTRIS study

Annals of oncology, 2018-11, Vol.29, p.ix158-ix158

2018

Volltextzugriff (PDF)

CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non-small cell lung cancer (EMERGING): A randomised study

Annals of oncology, 2018-10, Vol.29, p.viii738-viii738

2018

Volltextzugriff (PDF)

Co-occurring alterations in driver genes impact on EGFR-targeted therapy among patients with EGFR-mutant advanced non–small cell lung cancer

Annals of oncology, 2018-11, Vol.29, p.ix158-ix159

2018

Volltextzugriff (PDF)

Pamiparib, a novel PARP 1/2 inhibitor, monotherapy for gBRCAm patients with recurrent ovarian, fallopian, and primary peritoneal cancer: An open-label, multicenter, phase II trial in China

Annals of oncology, 2018-10, Vol.29, p.viii356-viii356

2018

Volltextzugriff (PDF)

The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer

Annals of oncology, 2014-12, Vol.25 (12), p.2372-2378

2014

Volltextzugriff (PDF)

Adolescents and young adults with cancer care in Asia: The joint ESMO/SIOPE/SIOP ASIA survey

Annals of oncology, 2018-11, Vol.29, p.ix121-ix121

2018

Volltextzugriff (PDF)

Biomarker-integrated study of single agent targeting molecular alterations of PI3KCA, MET, ALK, ROS1, KRAS, NRAS or BRAF in advanced NSCLC: Phase 2 umbrella trial in China (CTONG1505)

Annals of oncology, 2018-11, Vol.29, p.ix113-ix113

2018

Volltextzugriff (PDF)

44PPrognostic value of Ki-67 in patients with triple-negative breast cancer receiving neo-adjuvant or adjuvant chemotherapy: A systematic review and meta-analysis

Annals of oncology, 2019-05, Vol.30 (Supplement_3)

2019

Volltextzugriff (PDF)

185MO Preliminary results of niraparib combined with brivanib or toripalimab dual therapy evaluation in recurrent, metastatic and persistent cervical cancer (CQGOG0101): An open-label, two cohorts, phase II clinical trial

Annals of oncology, 2022-11, Vol.33, p.S1508-S1508

2022

Volltextzugriff (PDF)

1987P TROP-2 as a promising ADC target in penile squamous cell carcinoma that promotes cell proliferation by activating AKT through PKCα pathway

Annals of oncology, 2024-09, Vol.35, p.S1149-S1149

2024

Volltextzugriff (PDF)

1999P Expression heterogeneity of ADC-related targets between primary tumors and metastatic lymph nodes in advanced urothelial cancers

Annals of oncology, 2024-09, Vol.35, p.S1156-S1156

2024

Volltextzugriff (PDF)

1360P Updated patient-reported outcomes from the CROWN study: Analyses in first-line ALK+ patients with (w) and without (w/o) baseline brain metastases (BMs) and w or w/o central nervous system adverse events (CNS AEs)

Annals of oncology, 2023-10, Vol.34, p.S781-S782

2023

Volltextzugriff (PDF)

720MO IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients (pts) with advanced gynecological cancers (Gynecol C): Results from a phase I study

Annals of oncology, 2024-09, Vol.35, p.S551-S551

2024

Volltextzugriff (PDF)

Integration of expression rate and absolute cell counts of PD-1+ stromal tumour-infiltrating lymphocytes: Prognostic significance in esophageal squamous cell carcinoma

Annals of oncology, 2019-11, Vol.30, p.ix155-ix156

2019

Volltextzugriff (PDF)

63PControlling nutritional status (CONUT) score is a prognostic factor in patients with resected breast cancer

Annals of oncology, 2019-05, Vol.30 (Supplement_3)

2019

Volltextzugriff (PDF)

EGFR mutation in early-stage and advanced-stage lung adenocarcinoma: Based on large date in China

Annals of oncology, 2017-11, Vol.28, p.x120-x120

2017

Volltextzugriff (PDF)

Clinical characteristics and efficacy in non-small cell lung cancer patients with EGFR exon 20 insertion and EGFR amplification

Annals of oncology, 2019-11, Vol.30, p.ix169

2019

Volltextzugriff (PDF)

963P Discovery and validation of cfDNA methylation, AFP and ctDNA mutation for the early detection of hepatocellular carcinoma: A multicenter prospective study (ASCEND-Hep)

Annals of oncology, 2023-10, Vol.34, p.S601-S601

2023

Volltextzugriff (PDF)

1 – 25 von 315

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAnnals Of Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(315)
Mit Volltextzugriff
(315)

Publikationsform

Artikel
(315)

Sprache

Englisch
(315)

Erscheinungsjahr

n.n

Thema

Humans
(25)
Life Sciences & Biomedicine
(24)
Oncology
(24)
Science & Technology
(24)
Female
(17)
Middle Aged
(16)
Aged
(15)
Adult
(14)
Male
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Tumors
(13)
Antineoplastic Agents
(12)
Pharmacology. Drug Treatments
(12)
Gastroenterology. Liver. Pancreas. Abdomen
(7)
Aged, 80 And Over
(6)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(6)
Multiple Tumors. Solid Tumors. Tumors In Childhood
(6)
Non-Small-Cell Lung Cancer
(6)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(6)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Neu hinzugefügt

... seit 90 Tagen
(35)

Menü

Weitere Dienste

Einstellungen

Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy

Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial

Prognostic value of Ki-67 in patients with triple-negative breast cancer receiving neo-adjuvant or adjuvant chemotherapy: A systematic review and meta-analysis

Controlling nutritional status (CONUT) score is a prognostic factor in patients with resected breast cancer

Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial

Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild type advanced NSCLC

Pilot study of anxiety, depression, and quality of life in patients with the diagnosis of metastatic uveal melanoma

Osimertinib in advanced or metastatic non-small cell lung cancer patients with EGFR T790M mutation after treatment with EGFR-TKI: Interim analysis of China cohort from the single-arm, open-label, international, multi-center real-world ASTRIS study

CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non-small cell lung cancer (EMERGING): A randomised study

Co-occurring alterations in driver genes impact on EGFR-targeted therapy among patients with EGFR-mutant advanced non–small cell lung cancer

Pamiparib, a novel PARP 1/2 inhibitor, monotherapy for gBRCAm patients with recurrent ovarian, fallopian, and primary peritoneal cancer: An open-label, multicenter, phase II trial in China

The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer

Adolescents and young adults with cancer care in Asia: The joint ESMO/SIOPE/SIOP ASIA survey

Biomarker-integrated study of single agent targeting molecular alterations of PI3KCA, MET, ALK, ROS1, KRAS, NRAS or BRAF in advanced NSCLC: Phase 2 umbrella trial in China (CTONG1505)

44PPrognostic value of Ki-67 in patients with triple-negative breast cancer receiving neo-adjuvant or adjuvant chemotherapy: A systematic review and meta-analysis

185MO Preliminary results of niraparib combined with brivanib or toripalimab dual therapy evaluation in recurrent, metastatic and persistent cervical cancer (CQGOG0101): An open-label, two cohorts, phase II clinical trial

1987P TROP-2 as a promising ADC target in penile squamous cell carcinoma that promotes cell proliferation by activating AKT through PKCα pathway

1999P Expression heterogeneity of ADC-related targets between primary tumors and metastatic lymph nodes in advanced urothelial cancers

1360P Updated patient-reported outcomes from the CROWN study: Analyses in first-line ALK+ patients with (w) and without (w/o) baseline brain metastases (BMs) and w or w/o central nervous system adverse events (CNS AEs)

720MO IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients (pts) with advanced gynecological cancers (Gynecol C): Results from a phase I study

Integration of expression rate and absolute cell counts of PD-1+ stromal tumour-infiltrating lymphocytes: Prognostic significance in esophageal squamous cell carcinoma

63PControlling nutritional status (CONUT) score is a prognostic factor in patients with resected breast cancer

EGFR mutation in early-stage and advanced-stage lung adenocarcinoma: Based on large date in China

Clinical characteristics and efficacy in non-small cell lung cancer patients with EGFR exon 20 insertion and EGFR amplification

963P Discovery and validation of cfDNA methylation, AFP and ctDNA mutation for the early detection of hepatocellular carcinoma: A multicenter prospective study (ASCEND-Hep)

Aktive Filter

Suchergebnisse filtern